BYL719 50mg 50mg | Purity Not Available
Adooq Bioscience
BLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
More Information Supplier PageBLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
More Information Supplier PageBLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
More Information Supplier PageBLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
More Information Supplier PageBLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
More Information Supplier PageSkepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageSkepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageSkepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageSkepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageSkepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageBAY 61-3606 is a cell-permeable imidazopyrimidine compound that acts as a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity with no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src.
More Information Supplier Page